OXBDF
Price
$3.71
Change
-$0.17 (-4.38%)
Updated
Apr 2 closing price
Capitalization
374.71M
UBX
Price
$0.99
Change
-$0.00 (-0.00%)
Updated
Apr 4 closing price
Capitalization
15.18M
Ad is loading...

OXBDF vs UBX

Header iconOXBDF vs UBX Comparison
Open Charts OXBDF vs UBXBanner chart's image
Oxford Biomedica
Price$3.71
Change-$0.17 (-4.38%)
Volume$15K
Capitalization374.71M
Unity Biotechnology
Price$0.99
Change-$0.00 (-0.00%)
Volume$55
Capitalization15.18M
OXBDF vs UBX Comparison Chart
Loading...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OXBDF vs. UBX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OXBDF is a Hold and UBX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (OXBDF: $3.71 vs. UBX: $0.99)
Brand notoriety: OXBDF and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OXBDF: 267% vs. UBX: 66%
Market capitalization -- OXBDF: $374.71M vs. UBX: $15.18M
OXBDF [@Biotechnology] is valued at $374.71M. UBX’s [@Biotechnology] market capitalization is $15.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OXBDF’s FA Score shows that 0 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • OXBDF’s FA Score: 0 green, 5 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, both OXBDF and UBX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

UBX’s TA Score shows that 4 TA indicator(s) are bullish.

  • UBX’s TA Score: 4 bullish, 6 bearish.

Price Growth

OXBDF (@Biotechnology) experienced а -4.38% price change this week, while UBX (@Biotechnology) price change was -16.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

UBX is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OXBDF($375M) has a higher market cap than UBX($15.2M). UBX YTD gains are higher at: 1.393 vs. OXBDF (-31.233).
OXBDFUBXOXBDF / UBX
Capitalization375M15.2M2,467%
EBITDAN/A-25.12M-
Gain YTD-31.2331.393-2,242%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A23.2M-
Total DebtN/A23.5M-
FUNDAMENTALS RATINGS
OXBDF vs UBX: Fundamental Ratings
OXBDF
UBX
OUTLOOK RATING
1..100
8852
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
6388
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
9519

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UBX's Valuation (57) in the Biotechnology industry is in the same range as OXBDF (71) in the null industry. This means that UBX’s stock grew similarly to OXBDF’s over the last 12 months.

UBX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OXBDF (100) in the null industry. This means that UBX’s stock grew similarly to OXBDF’s over the last 12 months.

OXBDF's SMR Rating (94) in the null industry is in the same range as UBX (99) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to UBX’s over the last 12 months.

OXBDF's Price Growth Rating (63) in the null industry is in the same range as UBX (88) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to UBX’s over the last 12 months.

OXBDF's P/E Growth Rating (97) in the null industry is in the same range as UBX (100) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to UBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
UBX
RSI
ODDS (%)
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 24 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VLGEA36.93-0.37
-0.99%
Village Super Market
FSV167.01-4.48
-2.61%
FirstService Corp
TDS37.86-1.66
-4.20%
Telephone and Data Systems
CRM255.23-16.31
-6.01%
Salesforce
IOBT1.00-0.06
-6.07%
IO Biotech

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and IMMP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and IMMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
IMMP - OXBDF
23%
Poorly correlated
-3.59%
BPMC - OXBDF
21%
Poorly correlated
-3.22%
BDTX - OXBDF
21%
Poorly correlated
-4.43%
ATNM - OXBDF
21%
Poorly correlated
-8.55%
UBX - OXBDF
20%
Poorly correlated
-6.60%
More